Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 9

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 9
---
 Stock” refers to the common stock, par value $0.0001 per share, of CERo. “ Common Warrants” refers to the Public Warrants, Private Placement Warrants, the Conversion Warrants, the Series A Warrants and the Series C Warrants. “ Conversion Warrants” refer to the warrants initially issued by CERo Therapeutics, Inc. and converted into warrants to purchase Common Stock in connection with the Business Combination. “ Convertible Bridge Notes” refer to the senior secured convertible notes issued by Legacy CERo to certain Legacy CERo Stockholders, which automatically converted into shares of Common Stock upon Closing. “ Danforth” refers to Danforth Advisors, LLC. “ DGCL” refers to the Delaware General Corporation Law, as may be amended from time to time. “ dollars” or “ $” refers to U.S. dollars. “ Earnout Shares” refer to the Primary Earnout Shares, the Secondary Earnout Shares and the Tertiary Earnout Shares, collectively. v “ Exchange Act” refers to the Securities Exchange Act of 1934, as amended. “ FDA” refers to the U.S. Food and Drug Administration, or any successor agency thereto. “ Fee Modification Agreements” refers to the fee modification agreements between PBAX and certain third-party vendors and service providers, pursuant to which such vendors received shares of Common Stock in lieu of certain payments due to such vendors prior to Closing. “ First PIPE Financing” refers to the private placement pursuant to which we issued and sold, and the PIPE Investors purchased, shares of Series A Preferred Stock, the Series A Warrants and Preferred Warrants, on the terms and conditions set forth in the First Securities Purchase Agreement. “ First PIPE Registration Rights Agreement” refers to the Registration Rights Agreement, dated as of February 14, 2024, by and between CERo and certain PIPE Investors. “ First Securities Purchase Agreement” refers to the Amended and Restated Securities Purchase Agreement, dated as of February 14, 2024, by and among PBAX, Legacy CERo and certain PIPE Investors, pursuant to which CERo agreed to issue and sell 10,039 shares of Series A Preferred Stock, 6,127 Series A Warrants and 2,500 Preferred Warrants. “ Initial Public Offering” refers to the initial public offering of PBAX, which closed on October 8, 2021. “ Investor Rights Agreement” refers to the Investor Rights and Lock-up Agreement, dated February 14